Wolfgang Marguerre built Octapharma from a two-founder startup in 1983 into one of the world's largest privately owned plasma-products companies, using technical specialization, manufacturing expansion and long-term private ownership. [1][2]
He built expertise inside the plasma industry before founding Octapharma
Marguerre entered the plasma-products business at Baxter's Travenol Laboratories in the 1970s and later ran Revlon's plasma division, giving him specialized operating experience before he became an owner. [1]
In 1983 he and Robert Taub founded Octapharma in Switzerland after becoming convinced that safer plasma-derived treatments could be built around improved viral-inactivation technology. [1][2]
Marguerre later described the startup as beginning with little more than a desk, underscoring that Octapharma itself was built rather than inherited. [1]
Manufacturing control turned the startup into a global healthcare company
Octapharma acquired its first fractionation plant in Vienna near the end of the 1980s, transforming a 12-person business into a manufacturer with roughly 150 employees and control over its own production base. [1][2]
The reviewed record supports a primarily self-created fortune: Marguerre founded the company after a professional career and scaled it through product development, manufacturing and acquisitions. The evidence does not establish severe starting disadvantage, so the standard self-created anchor fits better than a higher score. [1][2]
Sources for background
Sources reviewed Sep 28, 2026.
- It started with a belief · Octapharma · Jun 2, 2023
- Milestones · Octapharma
Comparable Healthcare billionaires
Similar Healthcare billionaires by estimated net worth.
